Bio

Bio


I am currently postdoctoral research fellow pursuing immunotherapy research in the oncology department at Stanford University. My clinical training as a pediatric hematology oncology fellow at Memorial Sloan Kettering Cancer Center highlighted the desperate need for novel therapeutic options for a subtype of aggressive pediatric leukemia, Acute Myeloid Leukemia (AML). Despite our best standard of care for AML, long term survival rates range from 50-60% with an unacceptably high relapse rate of 40%. The urgent need for novel treatments inspired me to pursue a research project in adoptive immunotherapy, genetically modifying Tcells to express artificial T cell receptors, termed chimeric antigen receptors (CARs), that target AML specific antigens. In parallel to my clinical training, I constructed an AML specific CAR and demonstrated its ability to redirect T cell function mediating eradication of AML cells. As the field of CAR therapy rapidly advances, novel methods to optimize this therapeutic modality are imperative. To this end, supported by research demonstrating superior antitumor function of naïve derived effector T cells compared to central memory derived effector T cells, I am investigating whether preferential modification of naïve T cells to express CARs will generate a T cell subpopulation with increased efficacy. Consolidating my clinical and research experiences within highly academic institutes allows me to synthesize my pursuit of scientific rigor and commitment to the field of oncology, with a mission to achieve productive research and translatable results.

Honors & Awards


  • Betty Lee Fellowship, New York Presbyterian Hospital, Weill Cornell (2010)
  • Kurdyak International Health Elective Award, Center for International Health and University of Toronto (2006)
  • Ivan H. Smith Memorial Studentship Award, Cancer Care Ontario and Hospital for Sick Children (2005)
  • Faculty of Pure and Applied Science Scholarship, York University (2000, 2001, 2002)

Boards, Advisory Committees, Professional Organizations


  • Board Certification in General Pediatrics, American Board of Pediatrics (2010 - Present)
  • Member, American Society of Hematology (2012 - Present)
  • Member, American Society of Pediatric Hematology Oncology (2012 - Present)
  • Member, American Society of Clinical Oncology (2012 - Present)
  • Member, American Academy of Pediatrics (2007 - Present)

Professional Education


  • Fellow, Memorial Sloan-Kettering Cancer Center, Pediatric Hematology Oncology (2013)
  • Resident, New York Presbyterian Hospital- Weill Cornell, Pediatrics (2010)
  • Doctor of Medicine, University of Toronto Schools (2007)
  • Bachelor of Science, York University (2003)

Stanford Advisors


Research & Scholarship

Lab Affiliations


Stanford Medicine Resources: